NBRV insider filings

Nabriva Therapeutics plc — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-01-31. Screen NBRV transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for NBRV between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Nabriva Therapeutics plc

FiledFormInsiderReported transactionsSource
2023-01-314Gelone Steven P. — DirectorTax withholding (F): 140 @ $1.50EDGAR
2023-01-314Schroeder Theodore R — DirectorTax withholding (F): 431 @ $1.50EDGAR
2023-01-104Gelone Steven P. — President and COO, DirectorTax withholding (F): 5 @ $1.30EDGAR
2023-01-104Schroeder Theodore R — Chief Executive Officer, DirectorTax withholding (F): 11 @ $1.30EDGAR
2023-01-044Gelone Steven P. — President and COO, DirectorTax withholding (F): 3 @ $1.89EDGAR
2023-01-044Schroeder Theodore R — Chief Executive Officer, DirectorTax withholding (F): 5 @ $1.89EDGAR
2022-12-084Gelone Steven P. — President and COO, DirectorTax withholding (F): 4 @ $2.02EDGAR
2022-12-084Schroeder Theodore R — Chief Executive Officer, DirectorTax withholding (F): 9 @ $2.02EDGAR
2022-12-024Gelone Steven P. — President and COO, DirectorTax withholding (F): 3 @ $2.25EDGAR
2022-12-024Schroeder Theodore R — Chief Executive Officer, DirectorTax withholding (F): 5 @ $2.25EDGAR
2022-11-084Gelone Steven P. — President and COO, DirectorTax withholding (F): 4 @ $2.24EDGAR
2022-11-084Schroeder Theodore R — Chief Executive Officer, DirectorTax withholding (F): 10 @ $2.24EDGAR
2022-11-014Gelone Steven P. — President and COO, DirectorTax withholding (F): 3 @ $2.54EDGAR
2022-11-014Schroeder Theodore R — Chief Executive Officer, DirectorTax withholding (F): 5 @ $2.54EDGAR
2022-10-114Gelone Steven P. — President and COO, DirectorTax withholding (F): 4 @ $2.72EDGAR
2022-10-114Schroeder Theodore R — Chief Executive Officer, DirectorTax withholding (F): 9 @ $2.72EDGAR
2022-10-044Gelone Steven P. — President and COO, DirectorTax withholding (F): 3 @ $2.08EDGAR
2022-10-044Schroeder Theodore R — Chief Executive Officer, DirectorTax withholding (F): 5 @ $2.08EDGAR
2022-09-074Gelone Steven P. — President and COO, DirectorTax withholding (F): 89 @ $0.16EDGAR
2022-09-074Schroeder Theodore R — Chief Executive Officer, DirectorTax withholding (F): 225 @ $0.16EDGAR
2022-09-014Gelone Steven P. — President and COO, DirectorTax withholding (F): 61 @ $0.16EDGAR
2022-09-014Schroeder Theodore R — Chief Executive Officer, DirectorTax withholding (F): 107 @ $0.16EDGAR
2022-08-154Gelone Steven P. — President and COO, DirectorOption exercise (M): 93,400 (derivative) @ $0 · Option exercise (M): 46,700 (derivative) @ $0 · Option exercise (M): 93,400 (derivative) @ $0 · Option exercise (M): 46,700 (derivative) @ $0EDGAR
2022-08-154Dolan Daniel — Chief Financial OfficerOption exercise (M): 83,200 (derivative) @ $0 · Option exercise (M): 41,600 (derivative) @ $0 · Option exercise (M): 83,200 (derivative) @ $0 · Option exercise (M): 41,600 (derivative) @ $0EDGAR
2022-08-154Guico-Pabia Christine J. — Chief Medical OfficerOption exercise (M): 71,500 (derivative) @ $0 · Option exercise (M): 35,700 (derivative) @ $0 · Option exercise (M): 71,500 (derivative) @ $0 · Option exercise (M): 35,700 (derivative) @ $0EDGAR
2022-08-154Naftzger J. Christopher — General Counsel and Corp SecOption exercise (M): 63,200 (derivative) @ $0 · Option exercise (M): 31,600 (derivative) @ $0 · Option exercise (M): 63,200 (derivative) @ $0 · Option exercise (M): 31,600 (derivative) @ $0EDGAR
2022-08-154Schroeder Theodore R — Chief Executive Officer, DirectorOption exercise (M): 239,800 (derivative) @ $0 · Option exercise (M): 119,900 (derivative) @ $0 · Option exercise (M): 239,800 (derivative) @ $0 · Option exercise (M): 119,900 (derivative) @ $0EDGAR
2022-08-084Gelone Steven P. — President and COO, DirectorTax withholding (F): 89 @ $0.18EDGAR
2022-08-084Schroeder Theodore R — Chief Executive Officer, DirectorTax withholding (F): 225 @ $0.18EDGAR
2022-08-044Webster Stephen W — DirectorSale (S): 7,826 @ $0.19EDGAR
2022-08-044Broom Colin MD — DirectorSale (S): 5,339 @ $0.19EDGAR
2022-08-044CORRIGAN MARK — DirectorSale (S): 10,297 @ $0.19EDGAR
2022-08-044BURGESS DANIEL D — DirectorSale (S): 11,341 @ $0.19EDGAR
2022-08-034Dalton Lisa — DirectorTax withholding (F): 8,400 @ $0.18EDGAR
2022-08-034Gelone Steven P. — President and COO, DirectorTax withholding (F): 61 @ $0.18EDGAR
2022-08-034Bourdow Carrie L. — DirectorSale (S): 8,540 @ $0.17EDGAR
2022-08-034Rowland Charles A Jr — DirectorSale (S): 8,496 @ $0.17EDGAR
2022-08-034Schroeder Theodore R — Chief Executive Officer, DirectorTax withholding (F): 107 @ $0.18EDGAR
2022-07-074Gelone Steven P. — President and COO, DirectorTax withholding (F): 89 @ $0.18EDGAR
2022-07-074Schroeder Theodore R — Chief Executive Officer, DirectorTax withholding (F): 225 @ $0.18EDGAR
2022-07-014Gelone Steven P. — President and COO, DirectorTax withholding (F): 61 @ $0.18EDGAR
2022-07-014Schroeder Theodore R — Chief Executive Officer, DirectorTax withholding (F): 107 @ $0.18EDGAR
2022-06-074Gelone Steven P. — President and COO, DirectorTax withholding (F): 89 @ $0.20EDGAR
2022-06-074Schroeder Theodore R — Chief Executive Officer, DirectorTax withholding (F): 225 @ $0.20EDGAR
2022-06-024Gelone Steven P. — President and COO, DirectorTax withholding (F): 61 @ $0.21EDGAR
2022-06-024Schroeder Theodore R — Chief Executive Officer, DirectorTax withholding (F): 107 @ $0.21EDGAR
2022-05-094Gelone Steven P. — President and COO, DirectorTax withholding (F): 89 @ $0.26EDGAR
2022-05-094Schroeder Theodore R — Chief Executive Officer, DirectorTax withholding (F): 225 @ $0.26EDGAR
2022-05-034Gelone Steven P. — President and COO, DirectorTax withholding (F): 61 @ $0.31EDGAR
2022-05-034Schroeder Theodore R — Chief Executive Officer, DirectorTax withholding (F): 107 @ $0.31EDGAR

Recent 8-K events — Nabriva Therapeutics plc

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2023-07-318-K1.01 — Entry into a Material Definitive Agreement
1.02 — Termination of a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-07-248-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2023-07-078-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2023-06-018-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2023-02-068-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2023-01-208-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2023-01-098-K1.02 — Termination of a Material Definitive Agreement
?
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2022-11-288-K8.01 — Other EventsEDGAR
2022-11-108-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2022-10-048-K8.01 — Other EventsEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=NBRV returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs